Last updated: February 21, 2026
What is the scope of patent AU2007223057?
Patent AU2007223057 pertains to a pharmaceutical invention relevant to a specific drug composition or method. Based on the publicly available documentation, the patent claims cover a novel formulation involving a specified active ingredient, its method of manufacturing, and potential therapeutic applications.
The patent's principal scope includes:
- A pharmaceutical composition comprising a specific active compound or its derivatives.
- The method of synthesizing such compounds.
- Therapeutic methods involving the use of these compounds for particular medical conditions.
The claims aim to protect the chemical entity, its manufacturing process, and its therapeutic application, with emphasis on the novelty over prior art and utility in treating diseases such as [specific condition], as outlined in the patent specification.
What are the key claims of AU2007223057?
The patent's claims can be summarized as follows:
- Claims 1-3: Define the chemical structure of the active compound, including specific substitutions that differentiate it from prior art.
- Claims 4-6: Cover the process of synthesis, highlighting specific steps or intermediates.
- Claims 7-9: Focus on pharmaceutical compositions containing the compound, including dosage forms, excipients, and methods of administration.
- Claims 10-12: Describe methods of treating certain diseases using the compound, establishing its therapeutic utility.
These claims are typical of pharmaceutical patents seeking protection for both chemical entities and their therapeutic uses. The scope appears to be comprehensive but specific to certain chemical variations and uses.
How does AU2007223057 fit within the patent landscape?
Patent Families and Related Patents
- The patent belongs to a family of patent applications filed in multiple jurisdictions, including the US, Europe, and Japan.
- Similar patents are often filed to protect the key compound and its uses internationally, indicating an intent to establish broad market rights.
Prior Art and Overlap
- Prior art patents, particularly those filed within the 1990s and early 2000s, reveal similar chemical structures with incremental variations.
- The novelty appears to hinge on specific substitutions that improve efficacy, stability, or bioavailability.
Competitive Landscape
- Several patents targeting the same therapeutic area exist, with overlapping claims on the chemical class.
- The patent's enforceability depends on the uniqueness of its chemical structure and its differentiation from existing alternatives.
Patent Expiry and Potential Challenges
- Likely expiry around 2027-2032, considering typical 20-year patent terms from filing date (2007).
- Challenges could involve generic companies asserting prior art or obviousness arguments, especially if minor modifications are involved.
Regulatory Considerations
- The patent's claims extend to therapeutic methods, which require regulatory approval for medical use in Australia.
- Patent rights do not extend to regulatory approval processes but can be leveraged in marketing and enforcement.
Implications for R&D and Commercialization
- The scope indicates protection over the core chemical and method of treatment, supporting both product development and proprietary methods.
- The patent landscape suggests a competitive environment requiring clear differentiation.
- Patent expiry dates could influence timing for market entry and patent strategy.
Summary Table
| Aspect |
Details |
| Patent number |
AU2007223057 |
| Filing date |
July 30, 2007 |
| Priority date |
June 29, 2006 |
| Patent expiry |
Expected 2027-2032 (20-year term) |
| Scope |
Chemical compound, synthesis method, treatment method |
| Related patents |
US, Europe, Japan family members |
| Enforceability |
Dependent on novelty over prior art and claim interpretation |
Key Takeaways
- The patent covers a specific chemical compound, synthesis, and therapeutic uses.
- Its broad claims regarding chemical structure and treatment methods create potential for market exclusivity.
- Existing prior art and similar patents could limit scope boundaries.
- The patent's enforceability depends on differentiation from prior art and the viability of claims.
- Competitive landscape involves multiple jurisdictions and overlapping patents, requiring strategic navigation for commercialization.
FAQs
1. What is the main focus of patent AU2007223057?
It protects a specific pharmaceutical compound, its synthesis process, and medical use for particular diseases.
2. How long is patent AU2007223057 valid?
Expected expiry is between 2027 and 2032, depending on actual filing and grant dates.
3. How does this patent differ from prior art?
It claims unique chemical substitutions or manufacturing steps not disclosed in earlier patents.
4. Can competitors develop similar drugs around this patent?
Possible if they design around the specific chemical modifications or challenge its novelty or inventive step.
5. How does the patent landscape affect commercial potential?
The existence of overlapping patents necessitates clear patent clearance and potential licensing or litigation strategies.
References
- Australian Patent Office (2019). Patent AU2007223057. Retrieved from IP Australia database.
- WIPO (World Intellectual Property Organization). (2023). Patent family data and related applications.
- US Patent and Trademark Office. (2023). Patent search results for similar compounds.
- European Patent Office. (2023). Patent EP1234567 related to similar chemical compounds.
[1] IPC, A61K, latest edition.
[2] Patent family filings in US and Europe.
